Get 20% lifetime commission for referring investors to digrin.com
here.
LENZ Therapeutics, Inc. ( LENZ) - Key Metrics
LENZ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.17 | -$1.02 | -$1.23 | -$1.23 |
| 2026Q1 | $0.06 | -$1.32 | -$1.07 | -$1.07 |
| 2025Q4 | $0.05 | -$1.16 | -$1.06 | -$1.06 |
| 2025Q3 | $0.44 | -$0.59 | -$0.30 | -$0.32 |
| 2025Q2 | $0.18 | -$0.53 | -$0.41 | -$0.42 |
LENZ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -1.39 |
| 2026Q1 | 0% | -1.73 |
| 2025Q4 | 0% | -3.45 |
| 2025Q3 | 0% | -19.74 |
| 2025Q2 | 0% | -13.83 |
LENZ
Price: $3.27
52 week price:
Earnings Per Share: -4.17 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 112.2 million